American Healthcare REIT financials
$51.90−0.23%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $674.3M | $650.8M | $604.1M | $572.9M | $542.5M | $540.6M | $542.7M | $523.8M | $504.6M | $499.5M |
| Gross profit | $149.4M | $138.6M | $123.8M | $118.4M | $116.2M | $108.2M | $112.2M | $106.7M | $102.0M | $95.9M |
| Gross margin | 22.2% | 21.3% | 20.5% | 20.7% | 21.4% | 20.0% | 20.7% | 20.4% | 20.2% | 19.2% |
| Operating income | $42.4M | $38.4M | $36.4M | $42.5M | $46.4M | $16.7M | $39.3M | $33.8M | $31.7M | $24.8M |
| Net income | $30.6M | $23.7M | $10.8M | $55.9M | $9.9M | -$6.8M | -$31.8M | -$4.1M | $2.0M | -$3.9M |
| Net margin | 4.5% | 3.6% | 1.8% | 9.8% | 1.8% | −1.3% | −5.9% | −0.8% | 0.4% | −0.8% |
| Diluted EPS | $0.16 | $0.13 | $0.06 | $0.33 | $0.06 | $-0.04 | $-0.21 | $-0.03 | $0.01 | $-0.04 |
| EBITDA | $108.4M | $116.8M | $103.9M | $101.2M | $78.5M | $91.2M | $97.2M | $91.3M | $87.8M | $82.1M |
| Operating cash flow | $118.6M | $81.1M | $55.2M | $107.2M | $71.5M | $60.6M | $59.5M | $63.1M | $51.0M | $2.4M |
| Free cash flow | $70.9M | $42.8M | $7.0M | $74.8M | $44.6M | $39.4M | $29.8M | $39.2M | $32.5M | -$17.5M |
| Diluted shares | 193.3M | 188.0M | 179.5M | 169.8M | 161.1M | 156.9M | 153.8M | 133.7M | 130.7M | 104.3M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $156.9M | $119.4M | $114.8M | $147.4M | $133.5M | $86.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.44B | $1.55B | $1.55B | $1.56B | $1.62B | $1.73B |
| Total assets | $5.70B | $5.60B | $5.43B | $4.77B | $4.51B | $4.46B |
| Total liabilities | $1.96B | $2.08B | $2.07B | $2.05B | $2.04B | $2.16B |
| Shareholders' equity | $3.74B | $3.52B | $3.36B | $2.72B | $2.46B | $2.30B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology